Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00101959
NCT00101959
View on ClinicalTrials.gov
Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects
PHASE4
Withdrawn
INTERVENTIONAL
0
Timeline
Start Date
November 30, 2004
Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG
Rebif
Sponsors
Lead Sponsor
EMD Serono
All Listed Sponsors
lead
EMD Serono
INDUSTRY
NCT00101959 - Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects | Biotech Hunter | Biotech Hunter